Saeede Jafari
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Saeede Jafari has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
Ghobad Moradi
Social Determinants of Health Research Center, Research Institute for Health Development, Kurdistan University of Medical Sciences, Sanandaj, Iran
4 shared publicationsMohammad Aziz Rasouli
Social Determinants of Health Research Center, Research Institute for Health Development, Kurdistan University of Medical Sciences, Sanandaj, Iran
4 shared publicationsMohammad Mehdi Gouya
Iranian Center for Communicable Diseases Control, Ministry of Health and Medical Education, Tehran, Iran
4 shared publicationsParvin Mohamadi
Department of Medical Sciences, Sanandaj Branch, Islamic Azad University, Sanandaj, Iran
4 shared publicationsBushra Zareie
Social Determinants of Health Research Center, Research Institute for Health Development, Kurdistan University of Medical Sciences, Sanandaj, Iran
3 shared publications- Ghobad Moradi
Social Determinants of Health Research Center, Research Institute for Health Development Kurdistan University of Medical Sciences Sanandaj Iran
3 shared publications
Latest Publications
- Open Access
- 31 October 2020
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 20 (1) , 1-9
Prevalence of and risk factors for HBV and HCV among incarcerated people who inject drugs in Iran: A cross sectional study
This study aimed at determining the prevalence of and risk factors for hepatitis B virus (HBV) and hepatitis C virus (HCV) among incarcerated people who inject drugs (PWID) in Iran in 2015–16. The required data was collected from a database provided by Iranian national bio-behavioral surveillance surveys (BBSSs) on 11,988 prisoners selected from among 55 prisons in 19 provinces in 2015–16. The data on demographics and behavioral variables were collected through interviews and the status of exposure to HBV and HCV were determined using ELISA blood test. A total of 1387 individuals with a history of drug injection in their lifetime were enrolled into the study. Data were analyzed using the survey package in Stata/SE software, Version 14.0. Univariate and multivariate logistic regression tests were used to investigate the relationships between risk factors and outcomes. The mean age of the incarcerated PWID was 36.83 ± 8.13 years. Of all the studied subjects, 98.46% were male and 50.97% were married. The prevalence of HCV and HBV among the subjects were 40.52 and 2.46%, respectively. The prevalence of HCV was associated with age ≥ 30 years, being single, illiteracy and low level of education, prison term> 5 years, history of piercing, and extramarital sex in lifetime (P < 0.05). The prevalence of HCV is alarmingly high. In general, it is recommended to adopt measures to screen and treat patients with HCV and vaccinat incarcerated PWID without a history of vaccination against HBV.
- 31 October 2020
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 20 (1) , 1-9
Open AccessPrevalence of and risk factors for HBV and HCV among incarcerated people who inject drugs in Iran: A cross sectional study
This study aimed at determining the prevalence of and risk factors for hepatitis B virus (HBV) and hepatitis C virus (HCV) among incarcerated people who inject drugs (PWID) in Iran in 2015–16. The required data was collected from a database provided by Iranian national bio-behavioral surveillance surveys (BBSSs) on 11,988 prisoners selected from among 55 prisons in 19 provinces in 2015–16. The data on demographics and behavioral variables were collected through interviews and the status of exposure to HBV and HCV were determined using ELISA blood test. A total of 1387 individuals with a history of drug injection in their lifetime were enrolled into the study. Data were analyzed using the survey package in Stata/SE software, Version 14.0. Univariate and multivariate logistic regression tests were used to investigate the relationships between risk factors and outcomes. The mean age of the incarcerated PWID was 36.83 ± 8.13 years. Of all the studied subjects, 98.46% were male and 50.97% were married. The prevalence of HCV and HBV among the subjects were 40.52 and 2.46%, respectively. The prevalence of HCV was associated with age ≥ 30 years, being single, illiteracy and low level of education, prison term> 5 years, history of piercing, and extramarital sex in lifetime (P < 0.05). The prevalence of HCV is alarmingly high. In general, it is recommended to adopt measures to screen and treat patients with HCV and vaccinat incarcerated PWID without a history of vaccination against HBV.
- Open Access
- 30 October 2020
- Published by Springer Nature in Research Square
Prevalence and risk factors for HBV and HCV among incarcerated people who inject drugs in Iran: a cross sectional study
Background: This study aimed at determining the prevalence of and risk factors for hepatitis B virus (HBV) and hepatitis C virus (HCV) among incarcerated people who inject drugs (PWID) in Iran in 2015-16. Methods : The required data was collected from a database provided by Iranian national bio-behavioral surveillance surveys (BBSSs) on 11988 prisoners selected from among 55 prisons in 19 provinces in 2015-16. The data on demographics and behavioral variables were collected through interviews and the status of exposure to HBV and HCV were determined using ELISA blood test. A total of 1387 individuals with a history of drug injection in their lifetime were enrolled into the study. Data were analyzed using the survey package in Stata/SE software, Version 14.0. Univariate and multivariate logistic regression tests were used to investigate the relationships between risk factors and outcomes.Results : The mean age of the incarcerated PWID was 36.83 ± 8.13 years. Of all the studied subjects, 98.46% were male and 50.97% were married. The prevalence of HCV and HBV among the subjects were 40.52% and 2.46%, respectively. The prevalence of HCV was associated with age≥30 years, being single, illiteracy and low level of education, prison term>5 years, history of piercing, and extramarital sex in lifetime (P<0.05). Conclusions : The prevalence of HCV is alarmingly high. In general, it is recommended to adopt measures to screen and treat patients with HCV and vaccinat incarcerated PWID without a history of vaccination against HBV.
- 30 October 2020
- Published by Springer Nature in Research Square
Open AccessPrevalence and risk factors for HBV and HCV among incarcerated people who inject drugs in Iran: a cross sectional study
Background: This study aimed at determining the prevalence of and risk factors for hepatitis B virus (HBV) and hepatitis C virus (HCV) among incarcerated people who inject drugs (PWID) in Iran in 2015-16. Methods : The required data was collected from a database provided by Iranian national bio-behavioral surveillance surveys (BBSSs) on 11988 prisoners selected from among 55 prisons in 19 provinces in 2015-16. The data on demographics and behavioral variables were collected through interviews and the status of exposure to HBV and HCV were determined using ELISA blood test. A total of 1387 individuals with a history of drug injection in their lifetime were enrolled into the study. Data were analyzed using the survey package in Stata/SE software, Version 14.0. Univariate and multivariate logistic regression tests were used to investigate the relationships between risk factors and outcomes.Results : The mean age of the incarcerated PWID was 36.83 ± 8.13 years. Of all the studied subjects, 98.46% were male and 50.97% were married. The prevalence of HCV and HBV among the subjects were 40.52% and 2.46%, respectively. The prevalence of HCV was associated with age≥30 years, being single, illiteracy and low level of education, prison term>5 years, history of piercing, and extramarital sex in lifetime (P<0.05). Conclusions : The prevalence of HCV is alarmingly high. In general, it is recommended to adopt measures to screen and treat patients with HCV and vaccinat incarcerated PWID without a history of vaccination against HBV.
- Open Access
- 5 October 2020
- Published by Springer Nature in Research Square
Prevalence and risk factors for HBV and HCV among incarcerated people who inject drugs in Iran: a cross sectional study
Background: This study aimed at determining the prevalence of and risk factors for hepatitis B virus (HBV) and hepatitis C virus (HCV) among incarcerated people who inject drugs (PWID) in Iran in 2015-16. Methods: The required data was collected from a database provided by Iranian national bio-behavioral surveillance surveys (BBSSs) on 11988 prisoners selected from among 55 prisons in 19 provinces in 2015-16. The data on demographics and behavioral variables were collected through interviews and the status of exposure to HBV and HCV were determined using ELISA blood test. A total of 1387 individuals with a history of drug injection in their lifetime were enrolled into the study. Data were analyzed using the survey package in Stata/SE software, Version 14.0. Univariate and multivariate logistic regression tests were used to investigate the relationships between risk factors and outcomes.Results: The mean age of the incarcerated PWID was 36.83 ± 8.13 years. Of all the studied subjects, 98.46% were male and 50.97% were married. The prevalence of HCV and HBV among the subjects were 40.52% and 2.46%, respectively. The prevalence of HCV was associated with age≥30 years, being single, illiteracy and low level of education, prison term>5 years, history of piercing, and extramarital sex in lifetime (PConclusions: The prevalence of HCV is alarmingly high. In general, it is recommended to adopt measures to screen and treat patients with HCV and vaccinat incarcerated PWID without a history of vaccination against HBV.
- 5 October 2020
- Published by Springer Nature in Research Square
Open AccessPrevalence and risk factors for HBV and HCV among incarcerated people who inject drugs in Iran: a cross sectional study
Background: This study aimed at determining the prevalence of and risk factors for hepatitis B virus (HBV) and hepatitis C virus (HCV) among incarcerated people who inject drugs (PWID) in Iran in 2015-16. Methods: The required data was collected from a database provided by Iranian national bio-behavioral surveillance surveys (BBSSs) on 11988 prisoners selected from among 55 prisons in 19 provinces in 2015-16. The data on demographics and behavioral variables were collected through interviews and the status of exposure to HBV and HCV were determined using ELISA blood test. A total of 1387 individuals with a history of drug injection in their lifetime were enrolled into the study. Data were analyzed using the survey package in Stata/SE software, Version 14.0. Univariate and multivariate logistic regression tests were used to investigate the relationships between risk factors and outcomes.Results: The mean age of the incarcerated PWID was 36.83 ± 8.13 years. Of all the studied subjects, 98.46% were male and 50.97% were married. The prevalence of HCV and HBV among the subjects were 40.52% and 2.46%, respectively. The prevalence of HCV was associated with age≥30 years, being single, illiteracy and low level of education, prison term>5 years, history of piercing, and extramarital sex in lifetime (PConclusions: The prevalence of HCV is alarmingly high. In general, it is recommended to adopt measures to screen and treat patients with HCV and vaccinat incarcerated PWID without a history of vaccination against HBV.
- Open Access
- 1 May 2020
- Published by Elsevier in Anais Brasileiros de Dermatologia (Versão em Português)
- Vol. 95 (3) , 289-297
Tatuagem entre prisioneiros iranianos: resultados das duas pesquisas nacionais de rastreamento biocomportamental em 2015–2016
- 1 May 2020
- Published by Elsevier in Anais Brasileiros de Dermatologia (Versão em Português)
- Vol. 95 (3) , 289-297
Open AccessTatuagem entre prisioneiros iranianos: resultados das duas pesquisas nacionais de rastreamento biocomportamental em 2015–2016
- Open Access
- 20 March 2020
- Published by Elsevier in Anais Brasileiros de Dermatologia
- Vol. 95 (3) , 289-297
Tattooing among Iranian prisoners: results of the two national biobehavioral surveillance surveys in 2015–2016
- 20 March 2020
- Published by Elsevier in Anais Brasileiros de Dermatologia
- Vol. 95 (3) , 289-297
Open AccessTattooing among Iranian prisoners: results of the two national biobehavioral surveillance surveys in 2015–2016
- Open Access
- 21 February 2020
- Published by Springer Nature in Research Square
Prevalence and risk factors for HBV and HCV among incarcerated people who inject drugs in Iran: a cross sectional study
Background This study aimed at determining the prevalence and risk factors of hepatitis B virus (HBV) and hepatitis C virus (HCV) among incarcerated people who inject drugs (PWID) in Iran during 2015-16. Methods The required data was obtained from the Iranian national bio-behavioral surveillance surveys (BBSSs), which examined 11988 prisoners who were selected using multi-stage sampling from 55 prisons in 19 provinces during 2015-16. The demographic and behavioral status of these subjects were measured through interviews and HBV and HCV exposure were examined using ELISA test of blood samples. A total of 1387 individuals with a history of drug injection in their lifetime were enrolled into this study. Survey analysis was used to analyze the data. The univariate and multivariate logistic regression were used to investigate the relationships between risk factors and outcome. Results The mean age of the incarcerated PWID was 36.83 ± 8.13; of all, 98.46% were male, 50.97% were married, and 96.57% had non-academic education. The prevalence of HCV and HBV was 40.52% and 2.46%, respectively. HCV prevalence was associated with an age≥30 years, being single, non-academic education, prison term>5 years, history of piercing, and extramarital sex in lifetime (P<0.05). Conclusions The prevalence of HCV is alarmingly high. However, prison by facilitating the easy access to infected group can be considered as an opportunity to achieve the goal of eliminating HCV in the country. It is recommended to design interventions while considering the risk factors of prison term, piercing, and extramarital sex.
- 21 February 2020
- Published by Springer Nature in Research Square
Open AccessPrevalence and risk factors for HBV and HCV among incarcerated people who inject drugs in Iran: a cross sectional study
Background This study aimed at determining the prevalence and risk factors of hepatitis B virus (HBV) and hepatitis C virus (HCV) among incarcerated people who inject drugs (PWID) in Iran during 2015-16. Methods The required data was obtained from the Iranian national bio-behavioral surveillance surveys (BBSSs), which examined 11988 prisoners who were selected using multi-stage sampling from 55 prisons in 19 provinces during 2015-16. The demographic and behavioral status of these subjects were measured through interviews and HBV and HCV exposure were examined using ELISA test of blood samples. A total of 1387 individuals with a history of drug injection in their lifetime were enrolled into this study. Survey analysis was used to analyze the data. The univariate and multivariate logistic regression were used to investigate the relationships between risk factors and outcome. Results The mean age of the incarcerated PWID was 36.83 ± 8.13; of all, 98.46% were male, 50.97% were married, and 96.57% had non-academic education. The prevalence of HCV and HBV was 40.52% and 2.46%, respectively. HCV prevalence was associated with an age≥30 years, being single, non-academic education, prison term>5 years, history of piercing, and extramarital sex in lifetime (P<0.05). Conclusions The prevalence of HCV is alarmingly high. However, prison by facilitating the easy access to infected group can be considered as an opportunity to achieve the goal of eliminating HCV in the country. It is recommended to design interventions while considering the risk factors of prison term, piercing, and extramarital sex.
- Open Access
- 24 May 2016
- Vol. 30, 375
Is the status of diabetes socioeconomic inequality changing in Kurdistan province, west of Iran? A comparison of two surveys
Background: About 80% of deaths in 350 million cases of diabetes in the world occur in low and middle income countries. The aim of this study was to determine the status of diabetes socioeconomic inequality and the share of determinants of inequalities in Kurdistan Province, West of Iran, using two surveys in 2005 and 2009.
- 24 May 2016
- Vol. 30, 375
Open AccessIs the status of diabetes socioeconomic inequality changing in Kurdistan province, west of Iran? A comparison of two surveys
Background: About 80% of deaths in 350 million cases of diabetes in the world occur in low and middle income countries. The aim of this study was to determine the status of diabetes socioeconomic inequality and the share of determinants of inequalities in Kurdistan Province, West of Iran, using two surveys in 2005 and 2009.